• Mon espace de travail
  • Aide IRIS
  • Par Publication Par Personne Par Unité
    • English
    • Français
  • Se connecter
Logo du site

IRIS | Système d’Information de la Recherche Institutionnelle

  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
UNIL
  • English
  • Français
Se connecter
IRIS
  • Accueil
  • Personnes
  • Publications
  • Unités
  • Périodiques
  • Mon espace de travail
  • Aide IRIS

Parcourir IRIS

  • Par Publication
  • Par Personne
  • Par Unité
  1. Accueil
  2. IRIS
  3. Publication
  4. Transforming growth factor beta 1 gene expression in human airways.
 
  • Détails
Titre

Transforming growth factor beta 1 gene expression in human airways.

Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Thorax  
Auteur(s)
Aubert, J.D.
Auteure/Auteur
Dalal, B.I.
Auteure/Auteur
Bai, T.R.
Auteure/Auteur
Roberts, C.R.
Auteure/Auteur
Hayashi, S.
Auteure/Auteur
Hogg, J.C.
Auteure/Auteur
Liens vers les personnes
Aubert, John-David  
Liens vers les unités
Pneumologie  
ISSN
0040-6376
Statut éditorial
Publié
Date de publication
1994
Volume
49
Numéro
3
Première page
225
Dernière page/numéro d’article
232
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov't - Publication Status: ppublish
Résumé
BACKGROUND--Asthmatic airways have a characteristic deposition of connective tissue under the epithelial basement membrane, but the mediators involved in this alteration are unknown. Several authors have postulated that transforming growth factor beta 1 (TGF-beta 1) could be overexpressed in asthmatic airways. METHODS--Lung samples from 16 asthmatic patients, six patients with chronic obstructive pulmonary disease (COPD), and six non-obstructed smokers were analysed. RNA was extracted from these tissues to measure expression of TGF-beta 1 by Northern blot analysis using a cDNA probe for TGF-beta 1. The level of expression was quantitated by densitometry using glyceraldehyde 3-phosphate dehydrogenase mRNA as a control. TGF-beta 1 was localised to specific cell types in these lungs by immunohistochemical analysis using polyclonal antibodies specific for intracellular and extracellular TGF-beta 1. RESULTS--The 2.5 kb TGF-beta 1 mRNA was seen in all 18 samples analysed by Northern blotting and densitometric analysis showed no difference between the asthmatic group (mean (SD) 108% (43%)), the group with COPD (122% (33%)), and the non-obstructed group (100% (49%)). The TGF-beta 1 precursor was immunolocalised throughout the airway wall including the epithelium and in alveolar macrophages. The mature TGF-beta 1 was localised primarily within the connective tissue of the airway wall. These patterns of expression of both forms of TGF-beta 1 were similar in lungs from asthmatic patients, those with COPD, and controls. CONCLUSIONS--While TGF-beta 1 mRNA and protein are abundantly expressed in human lungs, there is no clear difference in expression between the airways of asthmatic subjects and those of smokers with and without COPD.
Sujets

Adolescent

Adult

Aged

Aged, 80 and over

Asthma

Blotting, Northern

Child

Child, Preschool

DNA Probes

Female

Gene Expression

Humans

Immunohistochemistry

Lung

Lung Diseases, Obstru...

Male

Middle Aged

RNA, Messenger

Smoking

Transforming Growth F...

PID Serval
serval:BIB_BF7261D75214
DOI
10.1136/thx.49.3.225
PMID
8202878
WOS
A1994NB39400008
Permalien
https://iris.unil.ch/handle/iris/179507
Open Access
Oui
Date de création
2008-01-21T11:54:05.741Z
Date de création dans IRIS
2025-05-21T00:54:28Z
  • Copyright © 2024 UNIL
  • Informations légales